跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLN-DIMETHYL FUMARATE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GLN-DIMETHYL FUMARATE
Authorized
STANDARD
GLN-DIMETHYL FUMARATE
glenmark pharmaceuticals canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cb116d4de8c26c06
Company
glenmark pharmaceuticals canada inc.
Type
Standard
Approval Details
Approval Id
cb116d4de8c26c06
Drug Approval Canada Name
GLN-DIMETHYL FUMARATE
Product Name
GLN-DIMETHYL FUMARATE
Status
Marketed
Status Date
2021-10-21
Original Market Date
2021-10-21
Din
02494817
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:20.00
Atc Original
L04AX07 DIMETHYL FUMARATE
Atc Name
l 04 ax 07
Aig Number
0154210002
Company Name
glenmark pharmaceuticals canada inc.
Company Address
1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2
Active Ingredients
DIMETHYL FUMARATE
240 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cb116d4de8c26c06
Type
Standard
Back to Health Canada Approvals